Go to main content

Combination Drugs

Exciting Recommendation from FDA Panel to Approve Basal Insulin/GLP-1 Combinations

Why Novo Nordisk and Sanofi’s combination drugs are potential gamechangers for type 2 diabetes. 

Soliqua: A New Injectable Combination Therapy for Type 2 Diabetes

A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe

GLP-1 Agonists: From 2 Daily Injections to 1 Per Week and Beyond

A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too